Cate Miller Goldstein

2 weeks ago | bain.com | Amanda Adler |Cate Miller Goldstein

It’s a moment of historic potential. As aging populations, cost pressures, and evolving care models fuel demand for greater medical innovation, fast-moving technologies like generative AI are opening countless doors for medtech companies to deliver it. At the same time, tariff turbulence and geopolitical uncertainty are calling for bolder, more decisive strategy. Even in this once-in-a-lifetime moment, the fundamentals of medtech haven’t changed.